Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial.
This is a very well designed large international study which studied efficacy and safety of rFVIIa in controlling upper gastrointestinal bleeding in cirrhotic patients. Eight doses of rFVIIa or placebo […]
Risks associated with transfusion of cellular blood components in Canada.
Comprehensive article on possible adverse reactions and risks of blood transfusion (43 pages). – Volker Kretschmer